Skip to main content
. 2021 Jun 17;28(10):5793–5799. doi: 10.1016/j.sjbs.2021.06.028

Table 6.

comparison between female migraine patients and control.

SNP Model Allele/
Genotype
Migraine
Female
N = 96
%
Control
N = 120
%
P value Crude Analysis
COR(95% Cl)
Adjusted Analysis
AOR(95% Cl)
P value


rs2651899 (PRDM16)
Allele A 102(53.12) 188(78.33) <0.001*** 3.190(2.100–4.846)
G 90(46.88) 52(21.67)

Genotype
AA 25(26.04) 78(65)
AG vs. AA 52(54.17) 32(26.67) <0.001*** 5.070(2.700–9.579) 6.813(3.247–14.293) <0.001***
GG vs. AA 19(19.79) 10(8.33) <0.001*** 5.928(2.438–14.412) 5.409(2.077–14.086) 0.001**
Dominant AA 25(26.04) 78(65)
AG + GG 71(73.96) 42(35) <0.001*** 5.274(2.923–9.518) 6.354(3.246–12.437) <0.001***


rs11172113 (LRP1)
Allele T 109(56.77) 166(69.16) 0.0078** 1.708(1.150–2.538)
C 83(43923) 74(30.83)

Genotype
TT 28(29.17) 53(44.16)
CT vs. TT 53(55.21) 60(50) 0.087* 1.672(0.928–3.011) 2.305(1.177–4.513) 0.015*
CC vs. TT 15(15.62) 07(5.84) 0.006** 4.056(1.481–11.106) 3.652(1.259–10.595) 0.017*
Dominant TT 28(29.17) 53(44.16)
CT + CC 68(70.83) 67(55.84) 0.024* 1.921(1.088–3.393) 2.529(1.331–4.806) 0.005**


rs10166942 (TRPM8)
Allele T 141(73.44) 198(82.5) 0.0228* 1.705(1.074–2.707)
C 51(26.56) 42(17.5)

Genotype
TT 51(53.13) 84(70)
CT vs. TT 39(40.62) 30(25) 0.011* 2.141(1.187–3.861) 2.653(1.326–5.307) 0.006**
CC vs. TT 06(6.25) 06(5) 0.409 1.647(0.504–5.381) 1.112(0.337–3.67) 0.862
Dominant TT 51(53.13) 84(70)
CT + CC 45(46.87) 36(30) 0.011* 2.059(1.177–3.603) 2.231(1.184–4.203) 0.013*

Data presented as number (N) and percentage (%)

COR; Crude odds ratio, AOR; Adjusted odds ratio Cl; Confidence Interval

*p < 0.05, **p < 0.01, ***p < 0.001 statistically significant

Adjusted for age and sex